Found 0 matching trials
Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/ Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181) PHASE3 In this study, participants with advanced or metastatic adenocarcinoma or s...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Longitudinal Plasma PD-L1 Testing With Immunotherapy in Lung Cancer NA This is a prospective pilot study to assess dynamic changes of plasma cell-...
Show More Location
Ballad Health Cancer Care
Learn More & Join Trial
PDL1 In Primary Colorectal Carcinoma and Its Prognostic Impact N/A Colorectal cancer (CRC) is a highly heterogenous disease. It the third most...
Show More Location
Multiple Locations
Learn More & Join Trial
Expression of Programmed Death Ligand-1 (PD-L1) in Nasopharyngeal and Hyypopharyngeal Carcinoma N/A Head and neck tumors comprise heterogeneous neoplasms that arise from surfa...
Show More Location
Sohag University Hospital
Learn More & Join Trial
Exosomes Implication in PD1-PD-L1 Activation in OSAS N/A An increased occurrence of cancer associated mortality has been described i...
Show More Location
Laboratoire du Sommeil, Département de Pneumologie, CHU d'Angers
Learn More & Join Trial
Association of BAL Fluid T-Cell Immune Activity With Tumor PD-L1 Expression and Its Prognostic Value: A Prospective Observational Study N/A This prospective observational study aims to evaluate whether immune profil...
Show More Location
SMG-SNU Boramae Medical Center
Learn More & Join Trial
SUV PDL1/PD1 in Sun Damaged & Sun Protected Human Skin of Participants NA The purpose of this research study is to look at how the proteins and genes...
Show More Location
University of Arizona Cancer Center
Learn More & Join Trial
Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC) N/A Observational, multicentre, retrospective study on patients taken care acco...
Show More Location
Centre Hospitalier D Argenteuil
Learn More & Join Trial
FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors PHASE1 This is a Phase 1 dose-finding study of FT536 given in combination with a m...
Show More Location
Honor Health Research Institute
Learn More & Join Trial
Neuroblastoma Precision Trial N/A This proposal sets forth the platform for a Precision Medicine clinical tri...
Show More Status
Active Not Recruiting
Location
Children's Hospital Los Angeles
Learn More & Join Trial